Prelude Therapeutics Incorporated
USD4.93
+0.55 (+12.56%)
CEO
Krishna Vaddi
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.39
Prev. Close
$4.38
Day Low
$4.35
Day High
$4.99
52W Low
$0.75
52W High
$5.54
Market Cap
$0.28B
Volume
0.47M
| -0.8 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -51.4% | -43.9% | 0.07 | 10.79 | -2.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -59.1% | -52.4% | 0.01 | 9.42 | -2.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -39.1% | -36.6% | 0.01 | 15.37 | -5.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -26.8% | -25.5% | 0.00 | 19.41 | -54.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 55.8% | -126.1% | -0.01 | 4.18 | -30.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 64.7% | -89.5% | 0.00 | 6.37 | -2.8 |
| -2.8 |
| 30 Sept 2025 | Q3 | 100.0% | -303.5% | -33.7% | -20.8% | 0.31 | 3.21 | -1.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -41.2% | -27.2% | 0.24 | 3.68 | -0.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -31.1% | -22.7% | 0.17 | 5.18 | -0.5 |
| 31 Dec 2024 | Q4 | 100.0% | -718.3% | -21.9% | -16.4% | 0.14 | 5.30 | -0.8 |
| 30 Sept 2024 | Q3 | 100.0% | -1075.7% | -20.6% | -16.4% | 0.12 | 7.04 | -1.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -19.1% | -15.5% | 0.10 | 7.83 | -2.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -14.9% | -12.7% | 0.08 | 11.64 | -2.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -14.0% | -11.9% | 0.07 | 10.79 | -2.2 |